Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Flunarizine

Flunarizine is a potent dual Na+/Ca2+ channel (T-type) blocker. Flunarizine is a D2 dopamine receptor antagonist. Flunarizine shows anticonvulsive and antimigraine activity, and peripheral vasodilator effects[1][2][3][4][5].

Product Specifications

CAS Number

[52468-60-7]

UNSPSC

12352005

Hazard Statement

H302-H315-H319-H335

Target

Calcium Channel; Dopamine Receptor; Sodium Channel

Type

Reference compound

Related Pathways

GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/flunarizine.html

Concentration

10mM

Purity

99.93

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

FC1=CC=C(C(N2CCN(C/C=C/C3=CC=CC=C3)CC2)C4=CC=C(F)C=C4)C=C1

Molecular Formula

C26H26F2N2

Molecular Weight

404.49

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501

References & Citations

[1]Hong-Seob So, et al. Protective effect of T-type calcium channel blocker flunarizine on cisplatin-induced death of auditory cells. Hear Res. 2005 Jun;204 (1-2) :127-39.|[2]Qing Ye, et al. Flunarizine blocks voltage-gated Na (+) and Ca (2+) currents in cultured rat cortical neurons: A possible locus of action in the prevention of migraine. Neurosci Lett. 2011 Jan 10;487 (3) :394-9.|[3]Celia M Santi, et al. Differential inhibition of T-type calcium channels by neuroleptics. J Neurosci. 2002 Jan 15;22 (2) :396-403.|[4]Novalbos J, et al. Effects of dotarizine and flunarizine on chromaffin cell viability and cytosolic Ca2+. Eur J Pharmacol. 1999 Feb 5;366 (2-3) :309-17.|[5]Wan L, et al. Mibefradil and Flunarizine, Two T-Type Calcium Channel Inhibitors, Protect Mice against Lipopolysaccharide-Induced Acute Lung Injury. Mediators Inflamm. 2020 Nov 10;2020:3691701.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Launched

Isoform

D2 Receptor

Citation 01

J Headache Pain. 2025 Jun 16;26 (1) :141.|bioRxiv. 2025 July 17.|J Ethnopharmacol. 2020 May 23;254:112727.|J Leukoc Biol. 2022 May;111 (5) :1021-1029.|Phytomedicine. 2025 Apr 11:142:156754.|Sci Rep. 2018 Nov 16;8 (1) :16932.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Lentiviral mouse Capg shRNA (UAS) - Lentiviral mouse Capg shRNA (UAS) (25)
GTR15192389 1 Vial

Lentiviral mouse Capg shRNA (UAS) - Lentiviral mouse Capg shRNA (UAS) (25)

Ask
View Details
Mouse Monoclonal Prostatic Acid Phosphatase/ACPP Antibody (ACPP/1338) [Janelia Fluor 646]
NBP2-54308JF646 0.1 mL

Mouse Monoclonal Prostatic Acid Phosphatase/ACPP Antibody (ACPP/1338) [Janelia Fluor 646]

Ask
View Details
Transforming Growth Factor beta1 (TGF beta 1, TGFb1, Camurati Engelmann Disease, CED, Diaphyseal Dysplasia 1 Progressive, DPD1, TGFb1, Differentiation inhibiting factor, Cartilage-inducing factor)
T8250-18 100 µg

Transforming Growth Factor beta1 (TGF beta 1, TGFb1, Camurati Engelmann Disease, CED, Diaphyseal Dysplasia 1 Progressive, DPD1, TGFb1, Differentiation inhibiting factor, Cartilage-inducing factor)

Ask
View Details
Ube2k (NM_016786) Mouse Tagged ORF Clone
MR202030 10 µg

Ube2k (NM_016786) Mouse Tagged ORF Clone

Ask
View Details